Langman CB, Greenbaum LA, Grimm P, Sarwal M, Niaudet P, Deschenes G, Cornelissen EA, Morin D, Cochat P, Elenberg E, Hanna C, Gaillard S, Bagger MJ, Rioux P (2014) Quality of life is improved and kidney function preserved in patients with nephropathic cystinosis treated for 2 years with delayed-release cysteamine bitartrate
it enhances cardiovascular health, reducing risks of heart disease, strokes, and diabetes, thus offering a comprehensive approach to promote long-lasting health improvement
[PMC free article] [PubMed] [CrossRef] [Google Scholar] Fulghesu AM, Ciampelli M, Muzj G, Belosi C, Selvaggi L, Ayala GF, Lanzone A
A pivotal 2023 randomized, double-blind, placebo-controlled clinical trial published in the prestigious Journals of Gerontology meticulously investigated the effects of GlyNAC supplementation in older adults suffering from severe glutathione deficiency and documented mitochondrial dysfunction